Logo Image
|Articles|January 27, 2023

Food and Drug Administration to Work with Congress on Creating Regulatory Framework for the Cannabidiol Market

Author(s)Erin McEvoy

A statement released on Thursday, January 26, 2023 from Dr. Janet Woodcock, the principal deputy commissioner of the Food and Drug Administration (FDA), announced that the FDA will work with Congress in formulating regulatory oversight to balance risk and access for products in the cannabidiol (CBD) market.

Our sister publication, Nutritional Outlook, provided thorough coverage of the FDA press release from Thursday, January 26th.

Click here to see the full article on this important update: https://www.nutritionaloutlook.com/view/fda-concludes-that-cbd-needs-its-own-regulatory-pathway-separate-from-dietary-supplements-and-food

Related to this article

View more
Image | adobe.stock/Maksim Kabakou
The Top 10 Articles from Cannabis Science and Technology in 2025
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Read more
Best of the Week: December 12 – December 18, 2025
Best of the Week: December 12 – December 18, 2025
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
Read more